CORCEPT THERAPEUTICS INC Interest Income, Debt Securities, Available-for-sale, Operating
CORCEPT THERAPEUTICS INC (CORT) reported Interest Income, Debt Securities, Available-for-sale, Operating of $72.00 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-04.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeDebtSecuritiesAvailableForSaleOperating · last filed 2020-08-04
- CORCEPT THERAPEUTICS INC interest income, debt securities, available-for-sale, operating for the quarter ending 2020-06-30 was -$105.00K, a 125.06% decline year-over-year.
- CORCEPT THERAPEUTICS INC interest income, debt securities, available-for-sale, operating for the quarter ending 2020-03-31 was $177.00K, a 72.08% decline year-over-year.
- CORCEPT THERAPEUTICS INC interest income, debt securities, available-for-sale, operating for the quarter ending 2019-09-30 was $360.00K, a 24.05% decline year-over-year.
- CORCEPT THERAPEUTICS INC interest income, debt securities, available-for-sale, operating for the quarter ending 2019-06-30 was $419.00K.
| Period end | Interest Income, Debt Securities, Available-for-sale, Operating 3 month | Interest Income, Debt Securities, Available-for-sale, Operating 6 month | Interest Income, Debt Securities, Available-for-sale, Operating 9 month |
|---|---|---|---|
| 2020-06-30 | -$105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $72.00K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $177.00K 10-Q · filed 2020-05-04 | ||
| 2019-09-30 | $360.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $779.00K derived: sum of 2 quarters · filed 2020-08-04 | $1.41M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $419.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $1.05M 10-Q · filed 2020-08-04 | |
| 2019-03-31 | $634.00K 10-Q · filed 2020-05-04 | ||
| 2018-09-30 | $474.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.02M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $546.00K 10-Q · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |